Last checked at 20 Jul 2020 08:55
LONDON MARKET OPEN: EU Summit Continues; AstraZeneca Vaccine In Focus
LONDON MARKET OPEN: EU Summit Continues; AstraZeneca Vaccine In Focus
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades4,572
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,646.00
Bid:
1,646.00
Ask:
1,646.50
Change:
6.50 (0.40%)
Spread:
0.50 (0.03%)
Open:
1,650.50
High:
1,656.00
Low:
1,637.00
Prev. Close:
1,639.50
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.20 Jul 2020 08:40
LIVE MARKETS-Opening snapshot: Risk-off on "Mission impossible"
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in Lon...
Read more20 Jul 2020 08:33
Glaxo To Invest In Germany's CureVac As Partner To Develop Vaccines
Glaxo To Invest In Germany's CureVac As Partner To Develop Vaccines
Read more20 Jul 2020 07:53
LIVE MARKETS-On the radar: Julius Baer, Philips, M&S, homebuilders
Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in Lon...
Read more20 Jul 2020 07:29
UPDATE 2-GSK buys 10% of CureVac in vaccine tech deal
* GSK invests 130 mln stg, CureVac could get further 606 mln stg* CureVac's mRNA experience complements GSK's expertise - exec* CureVac IPO expected in the autumn (Rewrites, adds source, CureVac comment on IPO)By Pushkala Aripaka and Arno Schuetze...
Read more20 Jul 2020 06:56
GSK takes 10% stake in CureVac for £130m in collaboration deal
(Sharecast News) - GlaxoSmithKline said it would invest £130m to take a 10% stake in Germany's CureVac and collaborate to develop up to five mRNA-based vaccines and antibodies to fight infectious diseases.
Read more15 Jul 2020 12:24
Wednesday broker round-up
(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.
Read more15 Jul 2020 09:25
UPDATE 2-UK stocks end higher on healthcare boost, growing vaccine hopes
* Potential Oxford/AstraZeneca vaccine news helps gains* U.S. health panel votes in favour of GSK's blood cancer drug* HSBC, Standard Chartered lag on Hong Kong tensions* ASOS jumps, Burberry slumps on mixed earnings updates (Updates to close)By Sh...
Read more15 Jul 2020 07:30
GlaxoSmithKline myeloma treatment gets nod from FDA committee
(Sharecast News) - GlaxoSmithKline announced on Wednesday that the oncologic drugs advisory committee of the US Food and Drug Administration (FDA) has voted in favour of "the demonstrated benefit" of monotherapy treatment with 'belantamab mafodotin'.
Read more15 Jul 2020 06:31
GSK's Belantamab Gets US Committee Nod But Awaiting FDA Green Light
GSK's Belantamab Gets US Committee Nod But Awaiting FDA Green Light
Read more13 Jul 2020 13:55
Morgan Stanley sees cycle turning higher for 'value' stocks
(Sharecast News) - Equity strategists at Morgan Stanley sounded a positive note on so-called 'value' stocks, arguing that the economic cycle was shifting into a 'recovery regime' - but there was catch.
Read more13 Jul 2020 12:48
JP Morgan says 'pent-up' demand will be exhausted, stays 'overweight' on Tech and Healthcare
(Sharecast News) - Equity strategists at JP Morgan believe that second quarter corporate results on both sides of the Atlantic may come in ahead of analysts' forecasts, helped by the fact that estimates were at very depressed levels.
Read more10 Jul 2020 17:47
UPDATE 1-UK says it will not join the EU's COVID-19 vaccine scheme
(Adds detail)By Kate HoltonLONDON, July 10 (Reuters) - Britain has turned down the chance to join a 2.4 billion euro ($2.7 billion) European Union plan to secure advance purchases of promising COVID-19 vaccines, saying the EU would not allow it a...
Read more10 Jul 2020 15:58
UPDATE 1-FDA unclear if benefits of GSK multiple myeloma drug outweigh risks
(Recasts, adds quotes, analyst comment)LONDON, July 10 (Reuters) - The U.S. Food and Drug Administration said on Friday it was unclear whether the benefits of GlaxoSmithKline's experimental treatment for a common form of blood cancer outweigh the ...
Read more10 Jul 2020 15:01
FDA says to review side effect of GSK's multiple myeloma drug
LONDON, July 9 (Reuters) - The U.S. Food and Drug Administration on Friday said it would review GlaxoSmithKline's experimental treatment for multiple myeloma, a common form of blood cancer, for a reported side-effect which affects the eyes of pat...
Read more